Researchers developed an AI model that accurately distinguishes between multiple dementia types using extensive, heterogeneous brain imaging data.
Key Details
- 1The model was trained and tested on 308,000 3D brain images from 17,000 patients collected over two decades.
- 2It detects vascular dementia, Alzheimer's, Lewy body dementia, Parkinson's, and mild cognitive impairment, with AUC >0.84 for these conditions.
- 3The dataset included multiple modalities (T1 MRI, T2 MRI, CT, PET), reflecting real-world clinical complexity and variation.
- 4The neural network is structured to handle varying numbers and types of images per patient (1–14), mitigating confounding variables like scanning site and age.
- 5Testing across multiple hospital sites demonstrated the model’s robustness to real-world heterogeneity.
- 6Future directions include larger datasets and development of explainable AI for neuroimaging disease detection.
Why It Matters
This study addresses a major barrier for clinical translation of imaging AI—performance on real-world, heterogeneous datasets—demonstrating a feasible path for deploying robust differential diagnostic tools across healthcare settings.
Source
EurekAlert
Related News
•EurekAlert
AI Tool Predicts Financial Toxicity Risk in Cancer Patients
Researchers developed a machine learning model to proactively identify cancer patients at high risk of financial stress from treatment.
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.